HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding
- PMID: 7705402
- DOI: 10.1002/eji.1830250315
HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding
Abstract
In human immunodeficiency virus (HIV) infection, sequence variations within defined cytotoxic T lymphocyte (CTL) epitopes may lead to escape from CTL recognition. In a previous report, we have shown that the variable central region of HIV Nef protein (amino acids 73-144) that contains potential CTL epitopes, can escape the CTL response. We suggested that this non recognition occurs through a variety of mechanisms. In particular, we provided evidence that HIV Nef sequences recovered from HLA-A11-expressing individuals have alterations in the major anchor residues essential for binding of the two Nef epitopes (amino acids 73-82 and 84-92) to the HLA-A11 molecule. Here, we investigate in more detail whether variations in autologous Nef sequences affect HLA binding, leading to CTL escape. Potential epitopes were sought by testing Nef peptides containing the HLA-A11-specific motif or related motifs. We confirmed that only the two previously described epitopes identified in cytolysis tests have optimal reactivity with the HLA-A11 molecule. We then sequenced several viral variants from donors that do not express the HLA-A11 molecule and compared the variability of these epitopes with those obtained from HLA-A11-expressing individuals. One substitution (Leu85) found in the sequences isolated from both populations increase the reactivity of the HLA-A11-restricted epitope 84-92, and might explain the difference in immunogenicity observed between the two HLA-A11-restricted epitopes from HLA-A11+ individuals. In addition, selective variations were only detected in virus isolated from HLA-A11-expressing individuals. Furthermore, examination of the association of variant peptides with the HLA-A11 molecule demonstrated that a single substitution within the minimal epitope could not always completely abrogate HLA binding, suggesting that multiple alterations within a particular epitope may accumulate during disease progression, allowing the virus to escape CTL recognition.
Similar articles
-
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.Virology. 2000 Jul 20;273(1):112-9. doi: 10.1006/viro.2000.0360. Virology. 2000. PMID: 10891413
-
Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.J Exp Med. 1994 Sep 1;180(3):1129-34. doi: 10.1084/jem.180.3.1129. J Exp Med. 1994. PMID: 7520468 Free PMC article.
-
Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.Tissue Antigens. 2005 Oct;66(4):305-13. doi: 10.1111/j.1399-0039.2005.00489.x. Tissue Antigens. 2005. PMID: 16185326
-
HIV's evasion of the cellular immune response.Immunol Rev. 1999 Apr;168:65-74. doi: 10.1111/j.1600-065x.1999.tb01283.x. Immunol Rev. 1999. PMID: 10399065 Review.
-
Comprehensive delineation of antigenic and immunogenic properties of peptides derived from the nef HIV-1 regulatory protein.Vaccine. 1993;11(11):1083-92. doi: 10.1016/0264-410x(93)90066-7. Vaccine. 1993. PMID: 8249426 Review.
Cited by
-
Memory CD8+ T cells in HIV infection.Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):363-7. doi: 10.1098/rstb.2000.0575. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 10794056 Free PMC article. Review.
-
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.J Virol. 1998 Feb;72(2):1403-10. doi: 10.1128/JVI.72.2.1403-1410.1998. J Virol. 1998. PMID: 9445041 Free PMC article.
-
Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.J Virol. 2008 Jan;82(1):138-47. doi: 10.1128/JVI.01452-07. Epub 2007 Oct 24. J Virol. 2008. PMID: 17959671 Free PMC article.
-
Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10581-6. doi: 10.1073/pnas.0504230102. Epub 2005 Jul 19. Proc Natl Acad Sci U S A. 2005. PMID: 16030147 Free PMC article.
-
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.J Clin Invest. 1996 Oct 1;98(7):1633-41. doi: 10.1172/JCI118958. J Clin Invest. 1996. PMID: 8833913 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials